UNSPSC 51282508: Cefatrizine

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N6O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8P4W949T8K, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-4-ylthio)methyl)-, (6r-(6alpha,7beta(r*)))- but generally known as cefatrizine, which bears US NIH Compound Identifier 40073.

UNSPSC 51282508 Cefatrizine, a Commodity code, shows minimal relevant recent procurement activity under its nominal scope. The four recent state and local opportunities tagged to this code—a Seminole County naloxone and drug deactivation systems bid, a Texas HHS therapeutic pharmacy initiative RFI, a Tampa Fire Department medical and first aid supplies invitation to bid, and a Minnesota Multistate Cooperative Purchasing Alliance generic pharmaceuticals RFP—involve naloxone, emergency medical supplies, and broad-based pharmaceutical procurement, not cefatrizine (a third-generation cephalosporin antibiotic) as a specified product. The mismatch between the code's nominal scope and the actual work being solicited suggests that state and local procurement offices are either tagging these opportunities incorrectly or using the code as a catch-all for pharmaceutical procurement more broadly. Issuing bodies include a county health department, a state HHS commission, a city fire department, and a multistate cooperative purchasing alliance serving state and local governments across multiple jurisdictions.

Geographic activity spans Florida (Seminole County), Texas (HHS Commission), Florida again (City of Tampa), and a multi-state cooperative anchored in Minnesota with participation including Oregon. The representative opportunities show a mix of notice types: an IFB for Seminole County (due July 26, 2023, though the posting date of June 30, 2026 suggests a data error in the source), an RFI from Texas HHS (response deadline April 3, 2026), an ITB from Tampa (due March 13, 2026, estimated value $700,000.00 with a 5% SLBE bid discount), and an RFP from MMCAP (due March 26, 2026). The Tampa procurement includes a sheltered-market designation for certified Small Local Business Enterprises. No evidence of current, active state or local procurement specifically for cefatrizine as a line-item pharmaceutical exists in the recent opportunity record.